As of 2025-12-23, the Relative Valuation of Terns Pharmaceuticals Inc (TERN) is (20.47) USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.64 USD, the upside of Terns Pharmaceuticals Inc based on Relative Valuation is -150.4%.
The range of the Relative Valuation is (19.96) - (21.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 20.0x | 19.2x |
| Forward P/E multiples | 19.0x - 20.8x | 19.9x |
| Fair Price | (19.96) - (21.01) | (20.47) |
| Upside | -149.1% - -151.7% | -150.4% |
| Date | P/E |
| 2025-12-19 | -38.06 |
| 2025-12-18 | -37.98 |
| 2025-12-17 | -40.04 |
| 2025-12-16 | -40.94 |
| 2025-12-15 | -41.98 |
| 2025-12-12 | -42.92 |
| 2025-12-11 | -44.92 |
| 2025-12-10 | -42.55 |
| 2025-12-09 | -40.61 |
| 2025-12-08 | -38.37 |
| 2025-12-05 | -28.01 |
| 2025-12-04 | -25.88 |
| 2025-12-03 | -26.22 |
| 2025-12-02 | -24.60 |
| 2025-12-01 | -26.26 |
| 2025-11-28 | -26.81 |
| 2025-11-26 | -27.42 |
| 2025-11-25 | -27.99 |
| 2025-11-24 | -26.75 |
| 2025-11-21 | -25.10 |
| 2025-11-20 | -24.91 |
| 2025-11-19 | -25.87 |
| 2025-11-18 | -26.29 |
| 2025-11-17 | -24.38 |
| 2025-11-14 | -21.52 |
| 2025-11-13 | -19.77 |
| 2025-11-12 | -19.36 |
| 2025-11-11 | -19.63 |
| 2025-11-10 | -18.24 |
| 2025-11-07 | -17.62 |
| 2025-11-06 | -17.41 |
| 2025-11-05 | -17.35 |
| 2025-11-04 | -16.63 |
| 2025-11-03 | -13.38 |
| 2025-10-31 | -7.88 |
| 2025-10-30 | -7.78 |
| 2025-10-29 | -7.65 |
| 2025-10-28 | -8.19 |
| 2025-10-27 | -7.69 |
| 2025-10-24 | -7.41 |
| 2025-10-23 | -7.15 |
| 2025-10-22 | -7.76 |
| 2025-10-21 | -7.75 |
| 2025-10-20 | -8.22 |
| 2025-10-17 | -8.02 |
| 2025-10-16 | -8.21 |
| 2025-10-15 | -8.11 |
| 2025-10-14 | -7.71 |
| 2025-10-13 | -7.82 |
| 2025-10-10 | -7.77 |